在接受化疗和放射治疗的患者中使用皮肤填充剂
Mia Panlilio1, Elizabeth Tchernogorova2, Binh Minh Nguyen1
1College of Osteopathic Medicine, Rocky Vista University, 8401 S Chambers Road, Parker, CO, 80112, United States, 1 9253236431.
JMIR dermatology
|September 9, 2025
概括
皮肤填充剂可能对接受化疗和放射治疗的癌症患者构成风险. 仔细的患者教育和个性化治疗计划对于减轻潜在的不良事件至关重要.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 医学美学 医学美学
背景情况:
- 皮肤填充剂是面部再生的流行,但它们在癌症患者的使用是复杂的.
- 化疗和放射治疗可以影响伤口愈合和免疫反应,影响填充剂的安全性和有效性.
- 与皮肤填充剂相关的潜在不良事件,虽然很少见,但在接受癌症治疗的患者中可能会恶化.
研究的目的:
- 突出在接受活性化疗和放射治疗的患者中使用皮肤填充剂的独特挑战和潜在风险.
- 要强调需要谨慎和个性化的方法来处理皮肤填充程序在这个患者群体.
- 强调关于高风险的彻底患者教育的重要性.
主要方法:
- 对皮肤填充剂并发症的现有文献的审查.
- 分析化疗和放射治疗对皮肤和愈合过程的潜在影响.
- 识别关于填充材料和癌症治疗之间的相互作用的知识差距.
主要成果:
- 化疗和辐射可以损害正常的愈合和免疫功能,增加与皮肤填充剂相关的风险.
- 皮肤填充剂很少与细胞炎和自身免疫综合征等疾病有关,这些疾病在癌症患者中可能更严重.
- 关于癌症疗法和填充材料之间的直接相互作用的研究有限,需要进一步调查.
结论:
- 临床医生必须彻底教育接受化疗和放射治疗的患者,了解皮肤填充剂注射的风险增加.
- 对于癌症患者,涉及皮肤填充剂的治疗计划需要仔细考虑和个性化,以尽量减少不良事件.
- 进一步的研究是必不可少的,以了解各种填充剂类型和并发癌症疗法之间的特定相互作用.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
606
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
606

